Elevated concentrations of BCAAs, both in plasma and tissues, have also been observed in the context of breast cancer, concomitant with increased expression of catabolic enzymes, including branched-chain amino acid transaminase 1 (BCAT1) (15). This evidence concerns the gene BCAT1 and breast carcinoma.